Abstract

ROZENFELD, Paula Adriana. Fabry disease in Argentina. Acta bioquím. clín. latinoam. [online]. 2016, vol.50, n.1, pp.17-25. ISSN 0325-2957.

A Fabry disease is an X-linked lysosomal disorder that results from a deficiency of the lysosomal enzyme alpha-galactosidase A. The implementation of biochemical and genetic tests for lysosomal diseases was carried out in our institution, the School of Exact Sciences, Universidad Nacional de La Plata. A successful approach for the detection of Fabry patients in Argentina was developed by constitutingan interdisciplinary group of professionals. A nephrological assessment of the Argentine patients detected was made andthe clinical manifestations of Fabry patients were analysed and recorded in a FOS international registry. Patients received their enzyme replacement therapy, and the infusion was offered at home. Research studies carried out by our group showed the existence of a proinflammatory state in cells from Fabry patients, which could be related to the pathophysiology. Approaching rare diseases is not easy, especially when there is a lack of State health care policies. This work led us to achieve objectives such as disseminate knowledge about the disease in our country, enhance clinical suspicion and improve accessibility to diagnosis and treatment for patients.

Keywords : Fabry disease; Lysosomal disorders; Diagnosis; Globotriaosylceramide.

        · abstract in Spanish | Portuguese     · text in Spanish     · Spanish ( pdf )